Canada· CA-DIN-02515776

TRELEGY ELLIPTA

A vilanterol, umeclidinium bromid und fluticason furoat product containing vilanterol (vilanterol trifenatate) + umeclidinium (umeclidinium bromide) + fluticasone furoate, registered in Canada by GLAXOSMITHKLINE INC. The same ATC class is registered in 11 of our 19 countries.

ATC R03AL08

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedTRELEGY ELLIPTAATCR03AL08REGISTER NO.CA-DIN-02515776PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Vilanterol, umeclidinium bromid und fluticason furoat is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AL08 (vilanterol, umeclidinium bromid und fluticason furoat), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose

Vilanterol, umeclidinium bromid und fluticason furoat · ATC R03AL08

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
VILANTEROL (VILANTEROL TRIFENATATE) + UMECLIDINIUM (UMECLIDINIUM BROMIDE) + FLUTICASONE FUROATE
Manufacturer
GLAXOSMITHKLINE INC
Country
Canada (CA)
ATC code
R03AL08
ATC class
Vilanterol, Umeclidinium bromid und Fluticason furoat
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d4c21674-3267-4d6e-bd14-21df740f7fa6
GET /v1/drugs/d4c21674-3267-4d6e-bd14-21df740f7fa6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02515776",
  "form": "POWDER",
  "class": "Human",
  "routes": [
    "INHALATION"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "R03AL08",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "100515",
  "strengths": [
    "25 MCG",
    "62.5 MCG",
    "200 MCG"
  ],
  "ahfs_class": null,
  "substances": [
    "VILANTEROL (VILANTEROL TRIFENATATE)",
    "UMECLIDINIUM (UMECLIDINIUM BROMIDE)",
    "FLUTICASONE FUROATE"
  ],
  "product_categorization": null
}

See everything about vilanterol, umeclidinium bromid und fluticason furoat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.